<

 
Data updated 2025-05-16 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date15763016.1 (espacenet)  (Federated)  (European Patent Register), 20150915
Patent/reg. no. and dateDK/EP 3193929, 20190612
Publication date20170726
Priority no. and dateUS 201462050948 P, 20140916, US 201462067642 P, 20141023, US 201462083929 P, 20141125, US 201462093141 P, 20141217, US 201462093124 P, 20141217
EP pub. no. and date EP 3193929 20170726
Effective date
Applicant/ownerInnate Pharma, 117, Avenue de Luminy
13009 Marseille, FR
Applicant ref. no.1511106
InventorPATUREL, Carine, 411 allée du Bois
F-69280 Marcy l'Etoile, FR,
ANDRE, Pascale, 38 rue de la Loubiere
F-13006 Marseille, FR,
BLERY, Mathieu, Les Hauts de Mazargues Bt D4
50 Bd du Vaisseau
F-13009 Marseille, FR,
SOULAS, Caroline, 11 Rue de Cluny
F-13008 Marseille, FR,
WAGTMANN, NicolaÃ?, 16 Avenue Joseph Liautaud
F-13260 Cassis, FR
RepresentativeRWS Group, RWS Compass House Vanwall Business Park, Vanwall Road Maidenhead, Berkshire SL6 4UB, GB
Opponent
IPC ClassA61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 29/00 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) 
TitleBEHANDLINGSREGIMER VED ANVENDELSE AF ANTI-NKG2A-ANTISTOFFER
Int. application no.EP2015071073
Int. publication no.WO2016041947
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact